| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |